Physician
Internal Medicine
Dr. Christopher C. Benz, MD
|
|
Give Review
Christopher Benz practices Internal Medicine. He studied medicine at University of Michigan Medical School. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Elected Member". Christopher C. Benz is a published doctor. He has 101 publications published. The most current publication "Long-term results (7 to 10 years) of endoscopic papillotomy for choledocholithiasis. Multivariate analysis of prognostic factors for the recurrence of biliary symptoms." He accepts Medicare.
Publications
- FOXM1 cistrome predicts Breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index.
- The Neoadjuvant Model is Still the Future for Drug Development in Breast Cancer.
- RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and Cancer cell growth.
- First pregnancy events and future Breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants.
- Phosphoprotein secretome of tumor cells as a source of candidates for Breast cancer biomarkers in plasma.
- mTORC1/C2 and pan-HDAC inhibitors synergistically impair Breast cancer growth by convergent AKT and polysome inhibiting mechanisms.
- The Cancer Genome Atlas Pan-Cancer analysis project.
- FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the Breast.
- Developing Safety Criteria for Introducing New Agents into Neoadjuvant Trials.
- Ligand Binding Promotes CDK-Dependent Phosphorylation of ER-Alpha on Hinge Serine 294 but Inhibits Ligand-Independent Phosphorylation of Serine 305.
- Biologic markers determine both the risk and the timing of recurrence in Breast cancer.
- Ribavirin Treatment Effects on Breast Cancers Overexpressing eIF4E, a Biomarker with Prognostic Specificity for Luminal B-Type Breast Cancer.
- A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative Breast cancer.
- Targeted quantitation of site-specific cysteine oxidation in endogenous proteins using a differential alkylation and multiple reaction monitoring mass spectrometry app...
- ErbB2 trafficking and degradation associated with K48 and K63 polyubiquitination.
- Protein acetylation and histone deacetylase expression associated with malignant Breast cancer progression.
- Systematic mapping of posttranslational modifications in human estrogen receptor-alpha with emphasis on novel phosphorylation sites.
- Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses Breast cancer metastasis.
- Unraveling the biologic and clinical complexities of HER2.
- Destabilization of ERBB2 transcripts by targeting 3' untranslated region messenger RNA associated HuR and histone deacetylase-6.
- A novel serine phosphorylation site detected in the N-terminal domain of estrogen receptor isolated from human Breast cancer cells.
- Estrogen receptor-negative Breast cancer is less likely to arise among lipophilic statin users.
- Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate Cancer cells.
- Proteasome-regulated ERBB2 and estrogen receptor pathways in Breast cancer.
- Meeting report: Translational Research at the Aging and Cancer Interface.
- Quantification of cysteine oxidation in human estrogen receptor by mass spectrometry.
- Type and duration of exogenous hormone use affects Breast cancer histology.
- Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b.
- Altered promoter usage characterizes monoallelic transcription arising with ERBB2 amplification in human Breast cancers.
- Breast cancer growth prevention by statins.
- Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.
- Validated high-throughput screening of drug-like small molecules for inhibitors of ErbB2 transcription.
- Clinical trials are required to prove the chemopreventive worth of statins.
- A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular Breast cancer subtypes.
- Rapid alteration of microRNA levels by histone deacetylase inhibition.
- Novel pathways associated with quinone-induced stress in Breast cancer cells.
- Reactivity of zinc finger cysteines: chemical modifications within labile zinc fingers in estrogen receptor.
- Vitamin K3 (menadione)-induced oncosis associated with keratin 8 phosphorylation and histone H3 arylation.
- Enhanced pharmacodynamic and antitumor properties of a histone deacetylase inhibitor encapsulated in liposomes or ErbB2-targeted immunoliposomes.
- Risk factors for estrogen receptor-positive Breast cancer.
- Clinical development of histone deacetylase inhibitors as antiCancer agents.
- Future directions of liposome- and immunoliposome-based Cancer therapeutics.
- Geographic excess of estrogen receptor-positive Breast cancer.
- Essential cysteine-alkylation strategies to monitor structurally altered estrogen receptor as found in oxidant-stressed Breast cancers.
- Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
- Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen.
- Redox control of zinc finger proteins.
- Sources of superoxide/H2O2 during mitochondrial proline oxidation.
- Label-Free Quantitation and Mapping of the ErbB2 Tumor Receptor by Multiple Protease Digestion with Data-Dependent (MS1) and Data-Independent (MS2) Acquisitions.
- Oxidant-sensitive protein phosphorylation in endothelial cells.
- Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes.
- The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells.
- Uridine and cytidine metabolism following inhibition of de novo pyrimidine synthesis by pyrazofurin.
- Use of high-dose oral methotrexate sequenced at 24 hours with 5-FU: a clinical toxicity study.
- Acute ulcer bleeding. A prospective randomized trial to compare Doppler and Forrest classifications in endoscopic diagnosis and therapy.
- Do we need the overtube for push-enteroscopy?
- Treatment of difficult intrahepatic stones by using extracorporeal and intracorporeal lithotripsy techniques: 10 years'' experience in 55 patients.
- The relationship between juxtapapillary duodenal diverticula and disorders of the biliopancreatic system: analysis of 350 patients.
- [Percutaneous and transpapillary laser lithotripsy of intrahepatic gallstones].
- Endoscopic biliary stenting for the palliation of pancreatic Cancer: results, survival predictive factors, and comparison of 10-French with 11.5-French gauge stents.
- Schedule-dependent cytotoxicity of methotrexate and 5-fluorouracil in human colon and Breast tumor cell lines.
- Transvalvular enteroscopy using a mother-baby endoscope system: a new approach to the distal ileum.
- Flow cytometric analysis of fluorescein-conjugated estradiol (E-BSA-FITC) binding in Breast cancer suspensions.
- Modulation of resistance to alkylating agents in Cancer cell by gossypol enantiomers.
- Randomized study comparing chemotherapy with and without estrogen priming in advanced Breast-cancer.
- Clinical pharmacokinetics of drugs used in the treatment of Breast cancer.
- Minilaparoscopy versus conventional laparoscopy in the diagnosis of hepatic diseases.
- The role of serum liver enzymes in the diagnosis of choledocholithiasis.
- Effect of S-adenosylmethionine versus tauroursodeoxycholic acid on bile acid-induced apoptosis and cytolysis in rat hepatocytes.
- [Severe complications in diagnostic laparoscopy. 9 years experience in 747 examinations].
- Pancreatic endoscopic sphincterotomy in patients with chronic pancreatitis: a single-center experience in 171 consecutive patients.
- [Liver abscesses--complications after prosthesis and stent occlusions].
- [Percutaneous transhepatic metal stents in therapy of bile duct stenoses].
- Noninvasive spectroscopic analysis of fluoropyrimidine metabolism in cultured tumor cells.
- Sequential infusions of methotrexate and 5-fluorouracil in advanced Cancer: pharmacology, toxicity, and response.
- Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenoCarcinoma HCT-8.
- Endoscopic therapy of adenomas of the papilla of Vater. A retrospective analysis with long-term follow-up.
- Prevalence and clinical importance of Helicobacter pylori infection in patients after partial gastric resection for peptic ulcer disease. A prospective evaluation of H...
- Long-term results (7 to 10 years) of endoscopic papillotomy for choledocholithiasis. Multivariate analysis of prognostic factors for the recurrence of biliary symptoms.
- Cytotoxicity of several chemotherapeutic agents in a human pancreatic Cancer cell line (Colo-357).
- Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study.
- [Long-term results of endoscopic balloon dilatation of ulcer-induced pyloric stenoses--follow-up of 25 patients].
- Oncogenes in human solid tumors.
- Inhibition of growth of leukemic cells by inhibitors of calmodulin: phenothiazines and melittin.
- Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon Carcinoma.
- Magnetic resonance imaging of implanted melanomas before and after chemotherapy. Relation to 31P magnetic resonance spectroscopy and tumor histology.
- Growth factors and their receptors.
- Long-term follow-up of patients with iron deficiency anemia after a close endoscopic examination of the upper and lower gastrointestinal tract.
- Enhancement of 5-fluorouracil antitumor effects by the prior administration of methotrexate.
- Chemoendocrine therapy with prolonged estrogen priming in advanced Breast cancer: endocrine pharmacokinetics and toxicity.
- Optimal schedule of methotrexate and 5-fluorouracil in human Breast cancer.
- Biochemical alterations during unperturbed suspension growth of L1210 cells.
- Endocrine-responsive pancreatic Carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
- Tamoxifen and 5-fluorouracil in Breast cancer: modulation of cellular RNA.
- Tamoxifen and 5-fluorouracil in Breast cancer: cytotoxic synergism in vitro.
- Detection of amplified oncogenes by differential polymerase chain reaction.
- Screening and characterization of estrogenic activity from a hydroxystilbene library.
- Consensus statement. Workshop on therapeutic resistance in Breast cancer: impact of growth factor signalling pathways and implications for future treatment.
- Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistance.
- Activated oncogenes and putative tumor suppressor genes involved in human Breast cancers.
Schools
University of Mi Med Sch
Vancouver General Hospital
Conditions Treated
- Breast Cancer
- Carcinoma in Situ
- Lung Cancer
- Secondary Malignancies
Doctors Specialties
- Medical Oncology
- Oncology
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Elected Member
Education
-
University of Michigan Medical School
Hospital
-
San Francisco General Hospital and Trauma Center
Drug Facts
| NPI NUMBER | 1457381014 | |
| NPPES Provider LastName | BENZ | |
| NPPES Provider FirstName | CHRISTOPHER | |
| NPPES Provider ZIPCode | 941153010 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 28.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1457381014 |
| Last Name Of The Provider | BENZ |
| First Name Of The Provider | CHRISTOPHER |
| View All |
Similar Doctors
|
|
Dr. Lissette Lopez, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jane M. Hightower, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. San S. Win, MD |
|
Dr. Michelle A. Malcolmson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eugene H. Fan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David R. Minor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Pourdehnad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles R. Gherman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Derald L. Seid, DO
This Doctor is OpenDoctor Recommended.
|